ACTO Technologies Raises $18M for Life Sciences Learning Expansion
ACTO Technologies Inc., a Toronto-based omnichannel learning and enablement platform for life sciences, has secured $18 million in Series B equity financing. The company plans to use the funds to fuel growth and explore strategic partnerships.
ACTO, which helps life science companies manage and deliver training content, announced the successful closure of its latest funding round. The investment was led by Questa Capital, with significant participation from existing investors, including Resolve Growth Partners, Salesforce Ventures, Panache Ventures, and MaRS Investment Accelerator Fund1.
The company will utilise the proceeds to accelerate its growth trajectory and scale its business. ACTO aims to expand its reach within the life sciences sector, offering innovative learning solutions to more clients. Additionally, ACTO will explore potential partnerships to enhance its platform and services.
ACTO Technologies Inc. has raised $18 million in Series B financing, with Questa Capital leading the round. The company will use the funds to grow rapidly, scale its business, and pursue strategic partnerships in the life sciences sector.
Read also:
- Small Business Owners Sound Alarm on Tariff Challenges
- THW Marks 75 Years of Saving Lives at Home and Abroad
- Kazakhstan's National Bank Boosts Currency Sales to $1.4 Trillion in Q4
- Federal petition from CEI seeking federal intervention against state climate disclosure laws, alleging these laws negatively impact interstate commerce and surpass constitutional boundaries.
